Thus, we illustrate a regulatory mechanism that cancer cell becomes adaptive to hypoxic microenvironment by copper-ion-mediated PKM2 activation, highlighting an essential role of PKM2-dependent metabolic plasticity during cancer progression, and revealing a protein-protein interaction pocket in the central of tetrameric PKM2 that could be targeted by a small molecule inhibitor for cancer treatment. Here, PKM is linked to cancer.